BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Clinical Research

Neomorph, Novo Nordisk Partner on Molecular Glue Degraders for Diseases

Collaboration leverages Neomorph's leading molecular glue discovery platform and Novo Nordisk's extensive expertise in cardiometabolic and rare diseases ...

March 27, 2024 | News

Oscotec/ ADEL Launch First Human Trial for Novel Alzheimer's Treatment ADEL-Y01

In a significant stride towards Alzheimer's disease (AD) treatment, Oscotec Inc. in collaboration with ADEL Inc., has announced the initiation of f...

February 26, 2024 | News

Immunofoco Achieves Historic Dual IND Approval for Groundbreaking EpCAM CAR-T Therapy

EpCAM, known for its presence in circulating tumor cells (CTCs) and high expression in primary and metastatic lesions of gastrointestinal tumors, r...

February 26, 2024 | News

CATUG and Crystal Bio Launch Joint Lab for Advanced Nucleic Acid Analysis

CATUG, a distinguished global entity specializing in integrated nucleic acid and drug delivery CRDMO services, is combining capabilities with Crystal ...

February 25, 2024 | News

Aptamer and Neuro-Bio enter the second phase of Alzheimer’s test development

This latest phase involves development of an additional Optimer binder against the innovative Neuro-Bio target implicated in Alzheimer’s disease, wit...

February 23, 2024 | News

RSSL Launches Innovation Hub for Biotech Support with Labs and Services

RSSL’s Innovation Hub will be a supportive ecosystem for early-stage biotech companies, providing a wide range of tailored services to help t...

February 22, 2024 | News

Thermo Fisher Scientific Awards Latest Oncomine Clinical Research Grants to Propel Oncology Advances

Thermo Fisher Scientific has unveiled the latest recipients of its Oncomine Clinical Research Grant, a prestigious accolade dedicated to advancing research...

February 21, 2024 | News

Neurophth Completes Enrollment for Opvika® LHON Gene Therapy Trial in the U.S.

Neurophth Therapeutics, Inc. ("Neurophth"), a pioneer in gene therapies, today announced the successful completion of patient enrollment for its Phase I/II...

February 20, 2024 | News

HKUST Neuroscientists Unveil Groundbreaking Blood Test for Alzheimer's with Over 96% Accuracy

Neuroscientists from the Hong Kong University of Science and Technology (HKUST), led by Prof. Nancy IP, have introduced a highly accurate universal diagnos...

February 20, 2024 | News

Japan Accelerates Approval Process for Groundbreaking Urothelial Cancer Treatment by Astellas

Astellas Pharma Inc. (TSE:4503, President and CEO: Naoki Okamura, "Astellas") announced that Japan's Ministry of Health, Labour a...

February 19, 2024 | News

Preclinical Data Reveals Promising Long-Term Immune Response from PIV5-based Intranasal Lyme Disease Vaccine

The research showcases mice inoculated with this innovative vaccine exhibiting enduring neutralizing antibody responses, providing protection for up to 15...

February 16, 2024 | News

PharusDx Secures Exclusive License for Breakthrough Pancreatic Cancer Biomarkers from City of Hope

Pharus Diagnostics ("PharusDx") has announced a global exclusive license agreement with City of Hope cancer center for proprietary biomarkers to be...

February 16, 2024 | News

Biointelect and CR2O Partner to Revolutionize Global Life Science Commercialization

Biointelect and CR2O have announced a strategic partnership aimed at delivering comprehensive commercialization solutions. This collaboration marks a miles...

February 15, 2024 | News

Brii Biosciences Secures Intellectual Property Rights for HBV Treatment from VBI Vaccines

Brii Biosciences Limited ("Brii Bio"), a leader in developing innovative treatments for diseases with significant unmet needs, has announced a strategic ac...

February 14, 2024 | News

Stay Connected